Locally Advanced Pancreatic Ductal Adenocarcinoma (original) (raw)
Treatment optimization of locally advanced and metastatic pancreatic cancer (Review)
Helder Mansinho
International Journal of Oncology, 2021
View PDFchevron_right
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Arnav Mehta
CA: A Cancer Journal for Clinicians, 2020
View PDFchevron_right
Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights
Christo Kole
Cancer Management and Research
View PDFchevron_right
A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score
Eric Assenat
Cancers, 2020
View PDFchevron_right
Therapeutic targets in the pancreatic adenocarcinoma microenvironment: past challenges and opportunities for the future
Journal of Cancer Metastasis and Treatment
Journal of Cancer Metastasis and Treatment, 2021
View PDFchevron_right
Improving outcomes for operable pancreatic cancer: Is access to safer surgery the problem?
David Chang
Journal of Gastroenterology and Hepatology, 2008
View PDFchevron_right
Prognostic and predictive markers in pancreatic adenocarcinoma
Sebastian Krug
Digestive and Liver Disease, 2016
View PDFchevron_right
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial
Jeffrey Clark
JAMA oncology, 2018
View PDFchevron_right
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study
Alice Wei
Journal of the National Comprehensive Cancer Network
View PDFchevron_right
Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma
Hirochika Toyama
Scientific Reports
View PDFchevron_right
ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer
Rajaram Sripadam
Journal of Clinical Oncology, 2020
View PDFchevron_right
Ductal pancreatic adenocarcinoma
Waldemar Uhl
Deutsches Ärzteblatt international, 2014
View PDFchevron_right
Neoadjuvant treatment of pancreatic ductal adenocarcinoma: present and future
Journal of Cancer Metastasis and Treatment
Journal of Cancer Metastasis and Treatment, 2022
View PDFchevron_right
Prognostic value of serum CEA and CA19‑9 levels in pancreatic ductal adenocarcinoma
El El Rammah, Abdalla Jebriel
Molecular and Clinical Oncology
View PDFchevron_right
Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
Julita Kulbacka
Gastroenterology Review, 2016
View PDFchevron_right
The Role of Radio-Frequency and Stereotactic Ablation in the Treatment of Pancreatic Cancer
iulia dogaru
Chirurgia
View PDFchevron_right
Nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreatic cancer: utility and experience from the clinic
DARIO GIUFFRIDA
Gastrointestinal Cancer: Targets and Therapy, 2016
View PDFchevron_right
Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies
Antonio Ghidini
Journal of Gastrointestinal Oncology
View PDFchevron_right
[Diagnostic and therapeutic recommendations in hypothalamic- hypophyseal dwarfism]
Grażyna Rydzewska
Kinderärztliche Praxis, 1988
View PDFchevron_right
World Journal of Gastroenterology Pancreatic adenocarcinoma: Beyond first line, where are we
Alberto Zaniboni
View PDFchevron_right
Pancreatic Cancer: Multicenter Prospective Data Collection and Analysis by the Hungarian Pancreatic Study Group
Gabriella Pár
Journal of gastrointestinal and liver diseases : JGLD, 2016
View PDFchevron_right
Pancreatic Adenocarcinoma in Young Adults in a Moroccan Population
Meryem Aitelhaj
Journal of Gastrointestinal Cancer, 2012
View PDFchevron_right
Ductal Pancreatic Adenocarcinoma: Surgery, Pathology Work-up, and Neoadjuvant, Adjuvant, and Palliative Treatments Reply
Waldemar Uhl
Deutsches Ärzteblatt International
View PDFchevron_right
Adjuvant therapy in pancreatic cancer: historical and current perspectives
Helmut Friess
Annals of Oncology, 2003
View PDFchevron_right
State of the art biological therapies in pancreatic cancer
Riccardo Casadei
World journal of gastrointestinal oncology, 2016
View PDFchevron_right
Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress
Luigi Pugliese
2020
View PDFchevron_right
Curative Treatment of Pancreatic Cancer: A Review
Shantanu Choubey
Zenodo (CERN European Organization for Nuclear Research), 2022
View PDFchevron_right
Pancreatic cancer from bench to bedside: molecular pathways and treatment options
Sofia Baka
Annals of translational medicine, 2016
View PDFchevron_right
KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
Eric Assenat
Clinical and Translational Gastroenterology, 2016
View PDFchevron_right
Is arterial infiltration still a criterion for unresectability in pancreatic adenocarcinoma?
Eduardo Diaz
Cirugía española, 2014
View PDFchevron_right
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
shuchi sehgal
Radiation Oncology Journal, 2021
View PDFchevron_right
Recent progress in pancreatic cancer
Christopher Wolfgang
CA: A Cancer Journal for Clinicians, 2013
View PDFchevron_right
A Patient With Stage III Locally Advanced Pancreatic Adenocarcinoma Treated With Intra-Arterial Infusion FOLFIRINOX: Impressive Tumoral Response and Death due to Legionella pneumophila Infection: A Unique Case Report
Dario de Ceglia
Frontiers in Oncology, 2022
View PDFchevron_right
Neoadjuvant Therapy and Vascular Resection During Pancreaticoduodenectomy: Shifting the Survival Curve for Patients with Locally Advanced Pancreatic Cancer
John Chabot
World Journal of Surgery, 2013
View PDFchevron_right
Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry
Amrita Chattopadhyay
Annals of Surgical Oncology
View PDFchevron_right